Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Andrew H. Wei, Hartmut Döhner, Christopher Pocock, Pau Montesinos, Boris Afanasyev, Hervé Dombret, Farhad Ravandi, Hamid Sayar, Jun-Ho Jang, Kimmo Porkka, Dominik Selleslag, Irwindeep Sandhu, Mehmet Turgut, Valentina Giai, Yishai Ofran, Merih Kizil Çakar, Aida Botelho de Sousa, Justyna Rybka, Chiara Frairia, Lorenza Borin, Germana Beltrami, Jaroslav Čermák, Gert J. Ossenkoppele, Ignazia La Torre, Barry Skikne, Keshava Kumar, Qian Dong, C.L. Beach, Gail J. Roboz

Open source

DOI
10.1056/nejmoa2004444
Published
2020-12-24
Container
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2004444,
  title = {Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission},
  author = {Andrew H. Wei and Hartmut Döhner and Christopher Pocock and Pau Montesinos and Boris Afanasyev and Hervé Dombret and Farhad Ravandi and Hamid Sayar and Jun-Ho Jang and Kimmo Porkka and Dominik Selleslag and Irwindeep Sandhu and Mehmet Turgut and Valentina Giai and Yishai Ofran and Merih Kizil Çakar and Aida Botelho de Sousa and Justyna Rybka and Chiara Frairia and Lorenza Borin and Germana Beltrami and Jaroslav Čermák and Gert J. Ossenkoppele and Ignazia La Torre and Barry Skikne and Keshava Kumar and Qian Dong and C.L. Beach and Gail J. Roboz},
  year = {2020},
  journal = {New England Journal of Medicine},
  doi = {10.1056/nejmoa2004444},
  url = {https://doi.org/10.1056/nejmoa2004444}
}

RIS

TY  - JOUR
TI  - Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
AU  - Andrew H. Wei
AU  - Hartmut Döhner
AU  - Christopher Pocock
AU  - Pau Montesinos
AU  - Boris Afanasyev
AU  - Hervé Dombret
AU  - Farhad Ravandi
AU  - Hamid Sayar
AU  - Jun-Ho Jang
AU  - Kimmo Porkka
AU  - Dominik Selleslag
AU  - Irwindeep Sandhu
AU  - Mehmet Turgut
AU  - Valentina Giai
AU  - Yishai Ofran
AU  - Merih Kizil Çakar
AU  - Aida Botelho de Sousa
AU  - Justyna Rybka
AU  - Chiara Frairia
AU  - Lorenza Borin
AU  - Germana Beltrami
AU  - Jaroslav Čermák
AU  - Gert J. Ossenkoppele
AU  - Ignazia La Torre
AU  - Barry Skikne
AU  - Keshava Kumar
AU  - Qian Dong
AU  - C.L. Beach
AU  - Gail J. Roboz
PY  - 2020
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa2004444
UR  - https://doi.org/10.1056/nejmoa2004444
ER  - 

APA

Wei, A. H., Döhner, H., Pocock, C., Montesinos, P., Afanasyev, B., Dombret, H., Ravandi, F., Sayar, H., Jang, J., Porkka, K., Selleslag, D., Sandhu, I., Turgut, M., Giai, V., Ofran, Y., Çakar, M. K., Sousa, A. B. D., Rybka, J., Frairia, C., Borin, L., Beltrami, G., Čermák, J., Ossenkoppele, G. J., Torre, I. L., Skikne, B., Kumar, K., Dong, Q., Beach, C., & Roboz, G. J. (2020). Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2004444

Source records